Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2016

Ausgabe 3/2016

Inhaltsverzeichnis ( 18 Artikel )

18.10.2016 | Editorial | Ausgabe 3/2016

Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery

Monika Brzezinska, Linda J. Williams, Jeremy Thomas, J. Michael Dixon

12.10.2016 | Review | Ausgabe 3/2016

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care

Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H. Partridge, Judy E. Garber

19.10.2016 | Review | Ausgabe 3/2016

Circulating tumor cells in breast cancer: applications in personalized medicine

Jin Sun Lee, Mark Jesus M. Magbanua, John W. Park

21.10.2016 | Review | Ausgabe 3/2016

Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trials

Fausto Petrelli, Sandro Barni, Giacomo Bregni, Filippo de Braud, Serena Di Cosimo

15.10.2016 | Preclinical study | Ausgabe 3/2016

miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients

András Lánczky, Ádám Nagy, Giulia Bottai, Gyöngyi Munkácsy, András Szabó, Libero Santarpia, Balázs Győrffy

18.10.2016 | Preclinical study | Ausgabe 3/2016

Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family

Ciyu Yang, Angela G. Arnold, Magan Trottier, Yukio Sonoda, Nadeem R. Abu-Rustum, Oliver Zivanovic, Mark E. Robson, Zsofia K. Stadler, Michael F. Walsh, David M. Hyman, Kenneth Offit, Liying Zhang

22.10.2016 | Preclinical study | Ausgabe 3/2016

Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA H1047R in HER2/ER-positive breast cancer

Feixiong Cheng, Junfei Zhao, Ariella B. Hanker, Monica Red Brewer, Carlos L. Arteaga, Zhongming Zhao

11.10.2016 | Clinical trial | Ausgabe 3/2016

Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems

Misun Choi, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im, Seok Jin Nam, Soo Youn Cho, Eun Yoon Cho

15.10.2016 | Clinical Trial | Ausgabe 3/2016 Open Access

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade

A. Hennigs, F. Riedel, F. Marmé, P. Sinn, K. Lindel, A. Gondos, K. Smetanay, M. Golatta, C. Sohn, F. Schuetz, J. Heil, A. Schneeweiss

17.10.2016 | Clinical trial | Ausgabe 3/2016 Open Access

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study

M. E. Cazzaniga, L. Cortesi, A. Ferzi, L. Scaltriti, F. Cicchiello, M. Ciccarese, S. Della Torre, F. Villa, M. Giordano, C. Verusio, M. Nicolini, A. R. Gambaro, L. Zanlorenzi, E. Biraghi, L. Legramandi, E. Rulli, On behalf of VICTOR Study Group

11.10.2016 | Epidemiology | Ausgabe 3/2016

Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients

M. C. van Maaren, L. de Munck, J. J. Jobsen, P. Poortmans, G. H. de Bock, S. Siesling, L. J. A. Strobbe

17.10.2016 | Epidemiology | Ausgabe 3/2016

Internal mammary node adenopathy on breast MRI and PET/CT for initial staging in patients with operable breast cancer: prevalence and associated factors

Hyejin Cheon, Hye Jung Kim, Sang-Woo Lee, Do-Hoon Kim, Chang-Hee Lee, Seung Hyun Cho, Kyung Min Shin, So Mi Lee, Gab Chul Kim, Won Hwa Kim

18.10.2016 | Epidemiology | Ausgabe 3/2016

Investigation of breast cancer sub-populations in black and white women in South Africa

Caroline Dickens, Ruth M. Pfeiffer, William F. Anderson, Raquel Duarte, Patricia Kellett, Joachim Schüz, Danuta Kielkowski, Valerie A. McCormack

21.10.2016 | Epidemiology | Ausgabe 3/2016

Use of complementary and alternative medicine and breast cancer survival in the Health, Eating, Activity, and Lifestyle Study

Marian L. Neuhouser, Ashley Wilder Smith, Stephanie M. George, James T. Gibson, Kathy B. Baumgartner, Richard Baumgartner, Catherine Duggan, Leslie Bernstein, Anne McTiernan, Rachel Ballard

21.10.2016 | Epidemiology | Ausgabe 3/2016

Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer risk

Mara A. Schonberg, Vicky W. Li, A. Heather Eliassen, Roger B. Davis, Andrea Z. LaCroix, Ellen P. McCarthy, Bernard A. Rosner, Rowan T. Chlebowski, Susan E. Hankinson, Edward R. Marcantonio, Long H. Ngo

22.10.2016 | Epidemiology | Ausgabe 3/2016

Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race

Chinwe C. Madubata, Ying Liu, Melody S. Goodman, Shumei Yun, Jennifer Yu, Min Lian, Graham A. Colditz

20.10.2016 | Erratum | Ausgabe 3/2016

Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient

Thomas M. Churilla, Brian L. Egleston, Colin T. Murphy, Elin R. Sigurdson, Shelly B. Hayes, Lori J. Goldstein, Richard J. Bleicher

24.09.2016 | Ausgabe 3/2016

Acknowledgement of reviewers 2015

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise